NVS Novartis AG
$145.46
Novartis AG (NVS) is expected to report earnings on October 26, 2026, before the market open. The consensus earnings estimate is $2.24 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -6.4% since its last earnings release on July 21, 2026.
Novartis AG Beat Consensus Estimates
Tuesday, July 21, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 26
Monday · Before Open
Earnings Whisper
-
vs $2.24
Rev est $14.55B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$150.17
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Novartis AG
Novartis AG is engaged in the research, development, manufacturing and marketing of healthcare products and pharmaceuticals.
Sector
Healthcare
Industry
Drug Manufacturers / Major
Held By 2 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.